96 - Featured Poster
Patient and physician factors associated with participation in Gynecologic Oncology Group (GOG) trials in cervical and uterine cancer
Monday, March 24, 2014: 7:09 AM
Room 13-16 (Tampa Convention Center)
S. E. Brooks1, R. L. Carter2, S. C. Plaxe3, K. M. Basen-Engquist4, M. Rodriguez5, J. L. Walker6, T. K. N. Myers7, J. G. Drake8, L. J. Havrilesky9, C. L. Brown10, L. Van Le11 and L. M. Landrum6
1Norton Healthcare, Louisville, KY, 2University at Buffalo and Gynecologic Oncology Group Statistical and Data Center, Buffalo, NY, 3UCSD Rebecca and John Moores Cancer Center, La Jolla, CA, 4The University of Texas MD Anderson Cancer Center, Houston, TX, 5Northern Indiana Cancer Research Consortium, Mishawaka, IN, 6The University of Oklahoma, Oklahoma City, OK, 7Baystate Medical Center, Longmeadow, MA, 8Waukesha Memorial Hospital, Waukesha, WI, 9Duke University Medical Center, Durham, NC, 10Memorial Sloan Kettering Cancer Center, New York, NY, 11University of North Carolina at Chapel Hill, Chapel Hill, NC
